Clinical Trials Browser

OTHER × Has results × ixabepilone × Clear all

NCT03093155 2024-05-14

Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab

Phase 2 Completed

78 enrolled 18 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT00630032 2024-02-21

TavIx

Phase 3 Completed

762 enrolled 14 charts

Breast Neoplasms

NCT00765765 2023-08-09

Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer

Phase 1/2 Terminated

6 enrolled 7 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01446016 2023-01-23

CAT

Phase 2 Completed

38 enrolled 11 charts

Breast Neoplasms

NCT00828308 2022-03-08

Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer

Phase 2 Completed

16 enrolled 7 charts

Prostatic Neoplasms

NCT00741988 2021-12-15

Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer

Phase 2 Completed

82 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung

NCT00866905 2021-11-22

Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer

Phase 2 Completed

168 enrolled 7 charts

Breast Neoplasms

NCT01097642 2021-09-22

ICE

Phase 2 Completed

40 enrolled 11 charts

Breast Neoplasms

NCT00627978 2018-06-26

Phase II Study of Ixabepilone in Metastatic Breast Cancer and Its Effects on the Ultrastructure of Neurons

Phase 2 Completed

15 enrolled 6 charts

Breast Neoplasms

NCT01012362 2017-12-28

Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

Phase 1 Terminated

31 enrolled 12 charts

BreastGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Sarcoma

NCT00789581 2017-07-02

TITAN

Phase 3 Completed

614 enrolled 10 charts

Breast Neoplasms

NCT00998738 2016-02-04

Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer

Phase 3 Terminated

1 enrolled 1 chart

Breast Neoplasms, Pain

NCT00821886 2014-12-22

Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer

Phase 2 Completed

60 enrolled 5 charts

Breast Neoplasms

NCT00825734 2014-12-22

Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer

Phase 1/2 Completed

83 enrolled 8 charts

Breast Neoplasms

NCT00924352 2014-10-13

Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer

Phase 1/2 Completed

56 enrolled 14 charts

Breast Neoplasms